Investing.com - Financial Markets Worldwide
Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Anika Therapeutics Inc (ANIK)

NASDAQ
Currency in USD
17.39
-0.33(-1.86%)
Real-time Data
ANIK Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Unlock Value
Day's Range
17.3017.61
52 wk Range
16.0029.12
Key Statistics
Edit
Prev. Close
17.72
Open
17.61
Day's Range
17.3-17.61
52 wk Range
16-29.12
Volume
19.94K
Average Vol. (3m)
87.68K
1-Year Change
-21.8%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANIK Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Sell
Analysts Sentiment
Buy
Price Target
26.50
Upside
+52.39%
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 8
Holds more cash than debt on its balance sheet
Unlock InvestingPro

Anika Therapeutics Inc News & Analysis

Show more

Anika Therapeutics Inc Company Profile

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company’s joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
345
Market
United States

Compare ANIK to Peers and Sector

Metrics to compare
ANIK
Peers
Sector
Relationship
P/E Ratio
−2.6x−1.5x−0.7x
PEG Ratio
0.01−0.010.00
Price / Book
1.4x1.7x2.6x
Price / LTM Sales
1.5x10.9x3.2x
Upside (Analyst Target)
49.5%321.8%44.5%
Fair Value Upside
Unlock19.2%6.6%Unlock

Analysts' Recommendations

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 26.50

(+52.39% Upside)

More details

People Also Watch

Information Services
3.720
III
+0.81%
Geospace
10.980
GEOS
+2.23%
Rocky Brands
21.81
RCKY
+0.51%
Nano Nuclear Energy
27.60
NNE
-0.04%
AtriCure
36.40
ATRC
+0.66%

FAQ

What Is the Anika (ANIK) Stock Price Today?

The Anika stock price today is 17.39

What Stock Exchange Does Anika Trade On?

Anika is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Anika?

The stock symbol for Anika is "ANIK."

What Is the Anika Market Cap?

As of today, Anika market cap is 259.52M.

What is Anika Earnings Per Share?

The Anika EPS is -6.62.

What Is the Next Anika Earnings Date?

Anika will release its next earnings report on Feb 20, 2025.

From a Technical Analysis Perspective, Is ANIK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.